BridgeBio Pharma (BBIO) PT Lowered to $26 at Jefferies
Tweet Send to a Friend
Jefferies analyst Eun Yang lowered the price target on BridgeBio Pharma (NASDAQ: BBIO) to $26.00 (from $28.00) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
